🇺🇸 FDA
Patent

US 7323173

Methods for treating breast cancer using a mammary cell growth inhibitor

granted A61KA61K48/00A61P

Quick answer

US patent 7323173 (Methods for treating breast cancer using a mammary cell growth inhibitor) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K48/00, A61P, A61P35/00, A61P35/04